8-K: Movano Health Secures Nasdaq Listing Extension

Movano Health has been granted an extension by Nasdaq to regain compliance with listing rules, including timely financial reporting and minimum bid price requirements.

Summary

• The Nasdaq Hearings Panel granted Movano Health an extension to continue its listing on Nasdaq.
• The company must file its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025, and June 30, 2025, on or before September 30, 2025.
• Movano Health must demonstrate compliance with the $1.00 per share minimum bid price rule on or before October 30, 2025.
• A Preliminary Proxy Statement was filed on August 19, 2025, for an Annual Shareholders Meeting on September 26, 2025, to approve a reverse stock split proposal to address the bid price rule.
• The company is actively working with its new auditor to complete and file the delinquent Quarterly Reports.

Sentiment

Score: 4

Explanation: While the extension prevents immediate delisting, the underlying issues of non-compliance with filing requirements and the need for a reverse stock split indicate significant operational and market challenges. The extension provides a reprieve but does not resolve the fundamental problems.

Positives

• Nasdaq granted an extension, preventing immediate delisting of the company's shares.
• Clear deadlines and a defined plan are now in place for the company to regain compliance with Nasdaq listing rules.
• The company is diligently working with a new auditor to resolve the outstanding financial filing delinquencies.
• A preliminary proxy statement has been filed for a reverse stock split, indicating proactive steps to address the minimum bid price requirement.

Negatives

• The company is currently non-compliant with Nasdaq listing rules regarding timely periodic report filings and maintaining a minimum bid price.
• Movano Health is delinquent in filing its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025, and June 30, 2025.
• The necessity of a reverse stock split often signals underlying stock price weakness and can be perceived negatively by investors, despite not changing fundamental value.
• There is a risk of further delays in completing financial filings or an inability to meet the established compliance deadlines.

Risks

• Potential inability to meet Nasdaq's requirements within the extension period granted by the Nasdaq Panel.
• Uncertainties associated with the company's preparation of the delinquent filings.
• Possibility of additional delays in the filing of the delinquent filings and the company's other SEC filings.
• Uncertainties associated with achieving the required shareholder vote necessary to approve a reverse stock split proposal.
• Other risks and uncertainties described in the company's SEC reports, including its most recent annual report on Form 10-K and quarterly reports on Form 10-Q.

Future Outlook

The company plans to regain compliance with Nasdaq's periodic filing rule by September 30, 2025, by completing and filing its delinquent Quarterly Reports on Form 10-Q. It also intends to achieve compliance with the minimum bid price rule by October 30, 2025, through a proposed reverse stock split, subject to shareholder approval.

Management Comments

• "The Company has and continues to work diligently with its new auditor to complete and file with the Securities and Exchange Commission (SEC) its Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025, and June 30, 2025, and expects to do so within the extension period granted by the Panel."

Industry Context

Companies in the health tech and wearable medical device sector, particularly smaller entities like Movano Health, frequently encounter challenges related to market valuation, operational scaling, and capital access. Maintaining a Nasdaq listing is critical for these companies to ensure market visibility and access to capital, making compliance issues like those Movano Health is addressing a significant concern within the industry.

Comparison to Industry Standards

• Maintaining a Nasdaq listing, including timely financial filings and a minimum bid price, is a fundamental standard for publicly traded companies. Movano Health is currently below these standards.
• Reverse stock splits are a common strategy employed by companies, especially smaller ones, to meet minimum bid price requirements, although they do not alter the company's intrinsic value.
• Delinquent financial filings represent a serious deviation from regulatory standards and can erode investor confidence, potentially leading to delisting.

Corporate Governance

Stakeholder Impact

• **Shareholders**: Face potential changes in share structure due to a reverse stock split and the ongoing risk of delisting if compliance deadlines are not met. The vote on the reverse stock split directly impacts their holdings.
• **Investors**: The persistent compliance issues and the necessity of a reverse stock split may raise concerns about the company's financial stability and operational effectiveness.
• **Employees**: While not directly mentioned, the uncertainty surrounding the company's listing status could indirectly affect employee morale and retention.

Next Steps

• Complete and file Quarterly Reports on Form 10-Q for Q1 and Q2 2025 by September 30, 2025.
• Hold the Annual Shareholders Meeting on September 26, 2025, to vote on the reverse stock split proposal.
• Demonstrate compliance with the $1.00 minimum bid price rule by October 30, 2025.

Key Dates

Recommendation

The granting of an extension by Nasdaq is a positive development as it avoids immediate delisting, which would be highly detrimental. However, the underlying issues of delinquent filings and a sub-$1.00 share price persist. The company has a clear plan and deadlines, but execution risk remains high, particularly with the need for shareholder approval for a reverse stock split and the timely completion of financial reports with a new auditor. Investors should hold to see if the company successfully executes its compliance plan, as failure could lead to delisting, while success could stabilize the stock.

Keywords

Movano Health, Nasdaq, Listing Compliance, Extension, Reverse Stock Split, Delinquent Filings, MOVE, Evie Ring, Wearable Medical Device, Healthcare Solutions